Author:
Dcruz Alison Celine,Vignesh Balaji E ,Manandhar Suman,Kumar Akshara,Gujaran Tanvi V.,Hedayat Paniz,Pai K. Sreedhara Ranganath
Funder
Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education
Reference103 articles.
1. BRAF in malignant melanoma progression and metastasis: potentials and challenges;Alqathama;Am. J. Cancer Res.,2020
2. BRAF inhibitors in metastatic non-small cell lung cancer;Anguera;J. Thorac. Dis.,2018
3. Overcoming resistance to BRAF inhibitors;Arozarena;Ann. Transl. Med.,2017
4. Combination therapies in advanced melanoma;Ascierto;Melanoma Manag.,2014
5. Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma;Ascierto;J. Clin. Oncol.,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献